← Eichor
Condition: Conversion Disorder Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Conversion Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Empowering Narratives
NA · 1 location(s) · Kristiania University College · NCT07062042Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT06571396FMT to Convert Response to Immunotherapy
Phase 1/Phase 2 · 1 location(s) · The Netherlands Cancer Institute · NCT05251389Pilot Neurobehavioral Therapy for Functional Neurological Disorder
NA · 1 location(s) · Rhode Island Hospital · NCT06873698FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of P
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07012798Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial
Phase 3 · 8 location(s) · Kaohsiung Veterans General Hospital. · NCT06727864Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients
Phase 4 · 1 location(s) · Massachusetts General Hospital · NCT06751992Promoting Improved Functioning Among People Experiencing Stressful Situations
NA · 5 location(s) · University of North Carolina, Chapel Hill · NCT06482567Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC
Phase 3 · 1 location(s) · Sahlgrenska University Hospital · NCT067146049-Step Magnetic Bariatric Revisional Surgery
Phase N/A · 1 location(s) · Unidad Internacional de Cirugia Bariatrica y Metabolica · NCT04945304Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer
Phase 2 · 1 location(s) · Jinbo Yue · NCT07007182EXPLOration of Processes Involved in Dissociative Identity Disorder (DID)
Phase N/A · 4 location(s) · Lille University · NCT07663890Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein T
Phase 2 · 1 location(s) · First Hospital of China Medical University · NCT07483359Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Guangxi Medical University · NCT06405321Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Im
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07056010Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal
Phase 2 · 1 location(s) · Chuangzhen Chen · NCT07339488The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Periton
Phase N/A · 1 location(s) · Ruijin Hospital · NCT06597526Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）
Phase 2 · 1 location(s) · Hebei Medical University Fourth Hospital · NCT06949111Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC
Phase 3 · 1 location(s) · Sun Yat-sen University · NCT06041477Feasibility of Remotely Measured Activity Behavior for Individuals With Functional Neurologic Disorder
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT07478666First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cor
Phase 1/Phase 2 · 1 location(s) · Yonsei University · NCT06922890CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients
Phase 2/Phase 3 · 1 location(s) · University of Wisconsin, Madison · NCT03769298Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Poten
Phase 2/Phase 3 · 2 location(s) · Shanghai Zhongshan Hospital · NCT06796803The Effects of fNIRS-based Neurofeedback Training on Balance and Gait in Parkinson's Disease
NA · 1 location(s) · National Yang Ming Chiao Tung University · NCT05800470Surgery for Locally Unresectable Pancreatic Cancer
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07241663Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma
NA · 1 location(s) · Peking University Cancer Hospital & Institute · NCT04047953Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer
Phase 2 · 1 location(s) · Fudan University · NCT07194005Virtual Reality in Functional Movement Disorder
NA · 1 location(s) · Medical University of Graz · NCT06393439Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases
Phase 3 · 1 location(s) · Fudan University · NCT04687631Investigation of Patients Presenting With Acute Functional Neurological Symptoms
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT07538414
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.